PERSENAIRE MAARTEN 4
4 · TELA Bio, Inc. · Filed Feb 26, 2021
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
PERSENAIRE MAARTEN
Chief Medical Officer
Transactions
- Award
Common Stock
[F1]2021-02-24+12,000→ 90,887 total - Award
Stock Option (right to buy)
[F2]2021-02-24+21,800→ 21,800 totalExercise: $16.99Exp: 2031-02-24→ Common Stock (21,800 underlying)
Footnotes (2)
- [F1]These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer.
- [F2]The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer.
Signature
/s/Nora Brennan, Attorney-in-fact|2021-02-26